Qsemble Capital Management’s Medtronic MDT Stock Holding History

Qsemble Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$468K	Sell	5,403 -8,910	-62%	-$854K	0.04%	359
2025 Q4	$1.37M	Buy	+14,313	New	+$1.39M	0.11%	234
2025 Q3	–	Sell	-42,343	Closed	-$3.69M	–	546
2025 Q2	$3.69M	Sell	42,343 -70,437	-62%	-$5.97M	0.35%	93
2025 Q1	$10.1M	Buy	112,780 +7,102	+7%	+$636K	1.08%	4
2024 Q4	$8.44M	Buy	105,678 +52,862	+100%	+$4.58M	1.12%	3
2024 Q3	$4.76M	Buy	52,816 +7,257	+16%	+$610K	0.88%	19
2024 Q2	$3.59M	Buy	+45,559	New	+$3.73M	0.68%	31
2024 Q1	–	Sell	-6,141	Closed	-$506K	–	485
2023 Q4	$506K	Buy	+6,141	New	+$468K	0.13%	242
2023 Q3	–	Sell	-18,600	Closed	-$1.64M	–	379
2023 Q2	$1.64M	Buy	18,600 +500	+3%	+$43K	1.16%	15
2023 Q1	$1.46M	Sell	18,100 -3,200	-15%	-$261K	0.98%	19
2022 Q4	$1.66M	Buy	+21,300	New	+$1.73M	1.15%	6

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qsemble Capital Management's MDT Position: Q1 2026 in Review

Qsemble Capital Management reduced its Medtronic (MDT) stake by 62% in Q1 2026, selling an estimated $854K and leaving 5,403 shares worth $468K. The position accounts for 0.04% of the portfolio, ranked #359.

Qsemble Capital Management first reported a position in MDT in Q4 2022 and has held it in 11 quarters since. The position peaked at $10.1M in Q1 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Qsemble Capital Management held 5,403 shares of Medtronic worth $468K as of Q1 2026.
Qsemble Capital Management sold 8,910 Medtronic shares in Q1 2026, an estimated $854K.
Medtronic made up 0.04% of Qsemble Capital Management's portfolio in Q1 2026, its #359 holding.
Qsemble Capital Management first reported a position in Medtronic in Q4 2022 and has held it in 11 quarters since.
Qsemble Capital Management's Medtronic position peaked at $10.1M in Q1 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Qsemble Capital Management's 13F filing for Q1 2026, filed 7 May 2026.